EUVIMEDEUVIMED entdecken
Crossref

Vagus nerve stimulation in lesional and Non-Lesional Drug-Resistant focal onset epilepsies

Rana Moshref, Jorge G Burneo, David A Steven, Seyed M Mirsattari, Michelle-Lee Jones, Jonathan Lau, Keith W MacDougall, Andrea Andrade, Sandrine de Ribaurpierre, Ana Suller Marti

Epilepsy & Behavior · 2024

DOI: 10.1016/j.yebeh.2024.109948 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsy & Behavior, 2024. Verfasst von Rana Moshref und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. Electronic addr…. Hauptthemen laut MEDLINE: Vagus Nerve Stimulation, Drug Resistant Epilepsy, Epilepsies, Partial. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Western University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Drug-resistant epilepsy (DRE) affects one-third of patients with focal epilepsy. A large portion of patients are not candidates for epilepsy surgery, thus alternative options, such as vagus nerve stimulation (VNS), are proposed. Our objective is to study the effect of vagus nerve stimulation on lesional versus non-lesional epilepsies. METHODS: This is a retrospective cohort study in a single center in London, Ontario, which includes patients with DRE implanted with VNS, implanted between 1997-2018 and the date of analysis is December 2023. PARTICIPANTS: Patients implanted with VNS were classified by lesional (VNS-L) and non-lesional (VNS-NL) based on their MRI head findings. We further subdivided the VNS groups into patients with VNS alone versus those who also had additional epilepsy surgeries. RESULTS: A total of 29 patients were enrolled in the VNS-L, compared to 29 in the VNS-NL. The median age of the patients in the study was 31.8 years, 29.31 % were men (N = 17). 41.4 % (n = 12) of the patients were VNS responders (≥50 % seizure reduction) in the VNS-L group compared to 62.0 % (n = 18) in the VNS-NL group (p = 0.03). When other epilepsy surgeries were combined with VNS in the VNS-L group, the median rate of seizure reduction was greater (72.4 (IQR 97.17-45.88) than the VNS-NL group 53.9 (IQR 92.22-27.92); p = 0.27). CONCLUSIONS: VNS is a therapeutic option for patients with lesional epilepsy, with slightly inferior results compared to patients with non-lesional epilepsy. Patients implanted with VNS showed higher seizure reduction rates if they had previous epilepsy surgeries. This study demonstrates that VNS in lesional epilepsies can be an effective treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vagus Nerve StimulationDrug Resistant EpilepsyEpilepsies, PartialHumansMaleFemaleAdultRetrospective StudiesYoung AdultMiddle AgedAdolescentTreatment OutcomeCohort StudiesMagnetic Resonance Imaging

Stichwörter der Autor:innen

EpilepsyLesionalMRIOutcomeSeizure reductionVagus nerve stimulation

Autor:innen und Institutionen

  • Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. Electronic address: rana.moshref@lhsc.on.ca.
  • Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada; Neuroepidemiology Unit, Schulich School of Medicine and Dentistry, Western University…
  • Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentist…
  • Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. Electronic address: seyed.mirsattari@lhsc.on.ca.
  • Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. Electronic address: michelle-lee.jones@lhsc.on.ca.
  • Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. Electronic address: jonathan.lau@lhsc.on.ca.

Förderung

  • Western University

Zitieren

APA

Moshref, R., Burneo, J. G., Steven, D. A., Mirsattari, S. M., Jones, M. L., Lau, J., MacDougall, K. W., Andrade, A., de Ribaurpierre, S., & Suller Marti, A. (2024). Vagus nerve stimulation in lesional and Non-Lesional Drug-Resistant focal onset epilepsies. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2024.109948

Vancouver

Moshref R, Burneo JG, Steven DA, Mirsattari SM, Jones ML, Lau J, et al. Vagus nerve stimulation in lesional and Non-Lesional Drug-Resistant focal onset epilepsies. Epilepsy & Behavior. 2024. doi:10.1016/j.yebeh.2024.109948

BibTeX
@article{Moshref2024,
  author = {Moshref, Rana and Burneo, Jorge G and Steven, David A and Mirsattari, Seyed M and Jones, Michelle-Lee and Lau, Jonathan and MacDougall, Keith W and Andrade, Andrea and de Ribaurpierre, Sandrine and Suller Marti, Ana},
  title = {Vagus nerve stimulation in lesional and Non-Lesional Drug-Resistant focal onset epilepsies},
  journal = {Epilepsy & Behavior},
  year = {2024},
  doi = {10.1016/j.yebeh.2024.109948}
}
Kostenlos starten →